Skip to main content
Contact
Site Search
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Press Releases
Home
>
News/Events
>
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
12/28/2017
Momenta Pharmaceuticals to Webcast Presentation at the 36th Annual J. P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)
11/01/2017
Momenta Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
11/01/2017
Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)
Download
PDF format download (opens in new window)
10/18/2017
Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
10/02/2017
Momenta Pharmaceuticals Promotes Ganesh V. Kaundinya as Chief Operating Officer and Chief Scientific Officer
Download
PDF format download (opens in new window)
08/30/2017
Momenta Pharmaceuticals to Webcast Presentation at the 2017 Wells Fargo Healthcare Conference
Download
PDF format download (opens in new window)
08/02/2017
Momenta Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
07/21/2017
Momenta Pharmaceuticals Announces Jury Verdict in Enoxaparin Sodium Injection Patent Litigation Against Amphastar
Download
PDF format download (opens in new window)
07/19/2017
Momenta Pharmaceuticals Announces Date of Second Quarter 2017 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
06/07/2017
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 38th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
06/01/2017
Momenta Pharmaceuticals Appoints Santiago Arroyo, M.D., Ph.D. as Chief Medical Officer
Download
PDF format download (opens in new window)
05/10/2017
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
05/02/2017
Momenta Pharmaceuticals Reports First Quarter 2017 Financial Results
Download
PDF format download (opens in new window)
04/26/2017
Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 42nd Annual Health Care Conference
Download
PDF format download (opens in new window)
04/18/2017
Momenta Pharmaceuticals Announces Date of First Quarter 2017 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
02/28/2017
Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference
Download
PDF format download (opens in new window)
02/21/2017
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results
Download
PDF format download (opens in new window)
02/17/2017
Momenta Pharmaceuticals Announces Time Change for Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
02/17/2017
Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer
Download
PDF format download (opens in new window)
02/17/2017
Momenta Pharmaceuticals Announces HSR Clearance for Collaboration and License Agreement with CSL
Download
PDF format download (opens in new window)
02/07/2017
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
02/01/2017
Momenta Pharmaceuticals to Webcast Presentation at the Leerink Partners 6th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
01/31/2017
Momenta Pharmaceuticals Announces District Court Decision to Invalidate Teva Pharmaceuticals Patents in COPAXONE® (glatiramer acetate injection) 40 mg/mL Litigation
Download
PDF format download (opens in new window)
01/06/2017
Momenta Provides Year-End 2016 Corporate Update
Download
PDF format download (opens in new window)
01/05/2017
Momenta and CSL Announce Collaboration and License Agreement to Develop Fc Multimer Programs, Including M230, a Selective Immunomodulator of Fc Receptors
Download
PDF format download (opens in new window)
01/03/2017
Momenta Pharmaceuticals to Webcast Presentation at the 35th Annual J. P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)